ClinicalTrials.Veeva

Menu

Kidney Disease and Pulmonary Hypertension

U

University of Giessen

Status

Completed

Conditions

Pulmonary Hypertension

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03045614
AZ 238/16

Details and patient eligibility

About

Evaluation of the prevalence of kidney disease, hemodynamic predictors and long-term renal outcome in patients with invasively diagnosed pulmonary hypertension.

Full description

This study aims to determine the prevalence of kidney disease, hemodynamic predictors and long-term renal outcome of in-hospital patients with invasively diagnosed pulmonary hypertension at the Department of Pulmonology, University Hospital Giessen and Marburg, Giessen, Germany between 1999 and 2016.

Enrollment

824 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • older than 18 years
  • subjects with invasively diagnosed pulmonary hypertension at rest and available renal function and spot urine data at day of right heart catheterization between March 1999 and December 2016 at the Department of Pulmonology, University Hospital Giessen and Marburg, Giessen, Germany

Exclusion criteria

  • subjects with estimated GFR <15ml/min/1.73m2 or prior dialysis
  • pre-existing acute kidney injury
  • non-end stage renal disease with extracorporeal or peritoneal ultrafiltration due to diuretic-resistant fluid overload
  • primary kidney disease requiring active immunosuppression
  • autosomal dominant polycystic kidney disease
  • if subjects are pregnant
  • if subjects are recipients of solid-organ transplants
  • subjects with pulmonary hypertension with unclear/multifactorial mechanisms (WHO group 5 pulmonary hypertension)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems